Acasa > Reviste de specialitate > Oncolog-Hematolog.ro > Acute myeloid leukemia cells in microscopic images
HEMATO-ONCOLOGY

Acute myeloid leukemia cells in microscopic images

 Imagini microscopice de celule leucemice mieloide

Stejara Nicoleta Mihai, Cristina Enache, Cristina Mambet, Ana Maria Vlădăreanu

First published: 18 decembrie 2023

Editorial Group: MEDICHUB MEDIA

DOI: 10.26416/OnHe.65.4.2023.8958

Abstract

Representative images of microscopic examination of May-Grünwald-Giemsa-stained bone marrow aspirate smears from patients with acute myeloid leukemia at diagnosis

Keywords
microscopic examination, May-Grünwald-Giemsa-stained bone marrow, myeloid leukemia cells

Rezumat

Representative images of microscopic examination of May-Grünwald-Giemsa-stained bone marrow aspirate smears from patients with acute myeloid leukemia at diagnosis

Cuvinte cheie
examinare microscopică celule leucemice mieloide May-Grünwald-Giems
Figure A-D. Representative images of microscopic examination of May-Grünwald-Giemsa-stained bone marrow aspi­rate smears from patients with acute myeloid leukemia (AML) at diagnosis. Distinct cytomorphological features of blast cells correlate with well-defined genetic AML types (A-C). AML myelodysplasia-related is usually diagnosed if ≥20% of mye­loid blasts are present in patients with a known history of myelodysplastic or myelodysplastic/myeloproliferative neo­plasms, such as chronic myelomonocytic leukemia (CMML). Dysplastic changes involving myeloid lineages are ob­served in bone marrow aspirate along with a high percentage of blast cells (D). Source: Collection of the Hematology Clinic of the Bucharest University Emergency Hospital; "Carol Davila" University of Medicine and Pharmacy, Bucharest
Figure A-D. Representative images of microscopic examination of May-Grünwald-Giemsa-stained bone marrow aspi­rate smears from patients with acute myeloid leukemia (AML) at diagnosis. Distinct cytomorphological features of blast cells correlate with well-defined genetic AML types (A-C). AML myelodysplasia-related is usually diagnosed if ≥20% of mye­loid blasts are present in patients with a known history of myelodysplastic or myelodysplastic/myeloproliferative neo­plasms, such as chronic myelomonocytic leukemia (CMML). Dysplastic changes involving myeloid lineages are ob­served in bone marrow aspirate along with a high percentage of blast cells (D). Source: Collection of the Hematology Clinic of the Bucharest University Emergency Hospital; "Carol Davila" University of Medicine and Pharmacy, Bucharest